✦ LIBER ✦

Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention

✍ Scribed by JoAnne Zujewski

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 76 KB
Volume: 39
Category: Article
ISSN: 0893-6692
DOI: 10.1002/em.10054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Selective Estrogen

ChemInform Abstract: Selective Estrogen Receptor Modulators (SERMs)

✍ T. A. GRESE; J. A. DODGE 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 2 views

Tetrahydroquinoline-Based Selective Estr

Tetrahydroquinoline-Based Selective Estrogen Receptor Modulators (SERMs).

✍ Owen B. Wallace; Kenneth S. Lauwers; Scott A. Jones; Jeffrey A. Dodge 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 107 KB 👁 1 views

2-Phenylspiroindenes: A Novel Class of S

2-Phenylspiroindenes: A Novel Class of Selective Estrogen Receptor Modulators (SERMs).

✍ Timothy A. Blizzard; Jerry D. II Morgan; Ralph T. Mosley; Elizabeth T. Birzin; K 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 90 KB 👁 2 views

Selective Estrogen-Receptor Modulators (

Selective Estrogen-Receptor Modulators (SERMs) in the Cyclopentadienylrhenium Tricarbonyl Series: Synthesis and Biological Behaviour

✍ Siden Top; Anne Vessières; Pascal Pigeon; Marie-Noëlle Rager; Michel Huché; Emma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

ChemInform Abstract: Photochemical Synth

ChemInform Abstract: Photochemical Synthesis of N-Arylbenzophenanthridine Selective Estrogen Receptor Modulators (SERMs).

✍ Timothy A. Grese; M. Dee Adrian; D. Lynn Phillips; Pamela K. Shetler; Lorri L. S 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 1 views

Clinical development of estrogen modulat

Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal vs. postmenopausal women

✍ Julia A. Lawrence; Phyllis B. Malpas; Caroline C. Sigman; Gary J. Kelloff 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

Tamoxifen has proven to be beneficial in the chemoprevention of breast cancer in women at increased risk for the disease. Other compounds that mediate the estrogen pathway remain to be tested for clinical efficacy. The mechanism of action, efficacy, and dose response of the estrogen modulators is de